Increase in the cancer population & surge in incidences of cardiac ailments, higher efficiency of the nuclear medicines for both diagnostics and therapeutics

PORTLAND, OREGON, UNITED STATES, December 29, 2021 /EINPresswire.com/ -- According to the report by Allied Market Research, titled, "Asia-Pacific Nuclear Medicine Market by Type (Diagnostics, Therapeutics, and Biochemistry Research), Modality (SPECT, PET, Beta emitters, Alpha Emitters, Brachytherapy, and Others), Application (Oncology, Cardiology, Thyroid, Neurology, ad Others) and End User (Hospitals & Diagnostic Centers and Research Institutes): Regional Opportunity Analysis and Industry Forecast, 2021–2028". The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.

The Asia-Pacific Nuclear Medicine Market was accounted for $4.11 billion in 2020, and is estimated to reach $8.95 billion by 2028, growing at a CAGR of 10.4% from 2020 to 2028.

For Right Perspective and Competitive Insights, Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/1253

Rise in incidence and prevalence of target conditions, developments in imaging technologies using radiopharmaceuticals, and surge in adoption of SPECT and PET scans have boosted the growth of the Asia-Pacific nuclear medicine market. Moreover, alpha radioimmunotherapy-based targeted cancer treatment supplemented the market growth. However, short half-life of radiopharmaceuticals, supply volatility, logistical challenges, and stringent regulatory policies coupled with competition from conventional alternative diagnostic procedures hinder the market growth. On the contrary, use of radiopharmaceuticals in neurological applications is expected to create lucrative opportunities for the market players in the future.

Comprehensive competitive analysis and profiles of major market players, such as

Bracco S.P.A. (Bracco Imaging S.P.A.)
Bwx Technologies, Inc. (Nordion, Inc.)
Cardinal Health, Inc.
Danaher Corporation (GE Healthcare)
FUJIFILM Toyama Chemical Co., Ltd. (FUJIFILM Holdings Corporation)
Ion Beam Applications (Ion Beam Applications, SA)
Lantheus Holdings, Inc. (Lantheus Medical Imaging, Inc.)
Novartis AG (Advanced Accelerator Applications S.A.)
Otsuka Holdings Co., Ltd. (ABX advanced biochemical compounds GmbH)
Siemens Healthcare GmbH

Key Findings Of The Study

By type, the diagnostics segment was the highest contributor to the Asia-Pacific nuclear medicine market in 2020.

By modality, the SPECT segment is anticipated to register highest revenue shares during the forecast period.

By application, the oncology segment is anticipated to gain highest revenue shares in the coming years.

By end user, hospitals & diagnostic centers segment is anticipated to gain highest revenue.

By country, China accounted for the largest revenue share in 2020; while India is anticipated to grow at the highest CAGR during the review period.

Get upto 25% Discount: https://www.alliedmarketresearch.com/purchase-enquiry/1253

FREQUENTLY ASKED QUESTIONS?

Q1. What is the market value of Asia-Pacific Nuclear Medicine Market report in forecast period?
Q2. What would be forecast period in the market report?
Q3. What is the market value of Asia-Pacific Nuclear Medicine Market in 2020?
Q4. Which is base year calculated in the Asia-Pacific Nuclear Medicine Market report?
Q5. Does the Asia-Pacific Nuclear Medicine Market company is profiled in the report?
Q6. Which are the top companies hold the market share in Asia-Pacific Nuclear Medicine Market?
Q7. Does the Asia-Pacific Nuclear Medicine Marketreport provides Value Chain Analysis?
Q8. What are the key trends in the Asia-Pacific Nuclear Medicine Market report?

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Orthopedic Joint Reconstruction Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Sleep Apnea Implants Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn